Related Experiment Video
Updated: Jan 26, 2026
12:55
P50 Sensory Gating in Infants
Published on: December 26, 2013
9.6K
Cefazolin pharmacokinetics in premature infants
Stephen J Balevic1,2, P Brian Smith1,2, Daniela Testoni3
1Duke Clinical Research Institute, Durham, NC, USA.
Summary
Pharmacokinetic data for cefazolin in premature infants is scarce. This study characterized cefazolin pharmacokinetics in infants born at ≤32 weeks gestation, finding lower clearance and higher volume of distribution, informing optimized dosing strategies.
Area of Science:
- Neonatal pharmacology
- Pediatric pharmacokinetics
- Infectious disease pharmacotherapy
Background:
- Limited pharmacokinetic (PK) data exists for cefazolin dosing in premature infants.
- Accurate dosing is crucial for efficacy and safety in this vulnerable population.
Purpose of the Study:
- To characterize cefazolin PK in infants born at or before 32 weeks of gestation.
- To inform optimized cefazolin dosing regimens for premature neonates.
Main Methods:
- Prospective, open-label PK and safety study.
- Intravenous cefazolin administration with timed and scavenged blood sample collection.
- Non-linear mixed-effects modeling and simulation of dosing regimens.
Main Results:
- Analysis of 40 samples from nine infants.
- Premature infants exhibited lower cefazolin clearance (median 0.03 L/h/kg) and greater volume of distribution (median 0.39 L/kg) compared to older children.
- Individual Bayesian estimates for clearance and volume of distribution were determined.
Conclusions:
- Simulations indicate that reduced cefazolin dosing, adjusted for postmenstrual age, can achieve target concentrations.
- Optimized dosing may improve therapeutic outcomes and minimize unnecessary drug exposure in premature infants.
Related Concept Videos
01:10Pharmacokinetics: Overview
9.4K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
9.4K
01:20Pharmacokinetic Models: Overview
2.0K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.0K
01:19Nonlinear Pharmacokinetics: Overview
1.1K
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.1K
01:22Nonlinear Pharmacokinetics: Causes of Nonlinearity
719
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
719
01:29Drug Dosing: Infants and Children
266
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
266
01:28Biopharmaceutics and Pharmacokinetics: Overview
4.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.0K